Research
Hormonal
Higher baseline plasma concentrations of inflammatory markers IL-6 and C-reactive protein (CRP) are associated with an increased risk of developing type 2 diabetes in middle-aged women.
For middle-aged women, high levels of inflammatory markers like CRP and IL-6 are strong predictors of future type 2 diabetes, even after accounting for weight. Managing inflammation through lifestyle may be a key strategy for diabetes prevention.
GoodSupportsHIGH confidence
Plasma concentrations of interleukin-6 and C-reactive protein are associated with an increased risk of developing type 2 diabetes mellitus in middle-aged women.
Why this rating
Prospective nested case-control study with strong statistical significance and adjustment for BMI and other factors.
Source
Dairy intake and the insulin resistance syndrome in the CARDIA Study.
Mark A. Pereira et al. · Circulation · 2001
DOI 10.1161/circ.103.suppl_1.9998-71
cohort
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Consuming at least one serving of fatty fish per week is associated with a significantly lower risk of death from ischemic heart disease in adults aged 65 and older.Good
- The hepatic lipase (HL) promoter polymorphism (HL-514T allele) modulates the effect of physical activity on HDL-C levels, with carriers of the T allele showing a blunted response to exercise-induced HDL increases.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →